Feto-Maternal Outcomes in Pregnancy with Fibroids
Keywords:
Intramural, fibroid, malpresentation, oligohydramnios, ultrasonographyAbstract
OBJECTIVE: To determine the fetal and maternal outcomes of pregnancy with fibroids.
METHODOLOGY: This prospective, case-series study was conducted at the Department of Obstetrics and Gynaecology, CMH Gujranwala, Pakistan, from July 2023 to June 2024. Females aged between 20-35 years, with singleton pregnancy, planned to undergo delivery with a diagnosis of single or multiple fibroids were analyzed. Maternal effects like pressure symptoms, urinary retention, abdominal pain, preterm delivery, and postpartum hemorrhage were noted. Fetal outcomes included miscarriage, oligohydramnios, intrauterine growth retardation, and abnormal presentation.
RESULTS: In a total of 81 women, the mean age was 26.22±3.56 years. The number of fibroids was 1, 2, 3, and more than 3 in 24 (29.6%), 23 (28.4%), 19 (23.5%), and 15 (18.5%) women, respectively. Fibroid size ranged from 3 to 5 cm in 45 (55.6%) women, while intramural fibroids were the most common type, noted in 51 (63.0%) women. The fibroids were located of the anterior wall in 38 (46.9%) women. Pressure-related symptoms were the most frequent types of complaints reported by 67(82.7%) women in pregnancy with fibroids. Oligohydramnios was found in 18(22.2%) babies, whereas intrauterine growth retardation was observed in 17(21.0%). 25 (31.6%) babies were born preterm. Malpresentation was observed in 29(35.8%) cases.
CONCLUSION: Intramural fibroids were the most common type of fibroids in pregnancy, while the anterior wall was the most common location. Pressure-related symptoms were the most frequent complaints in pregnancy with fibroids. Nearly one-third of the newborns are at risk of preterm birth or malpresentation.
References
1. Cramer SF, Patel A. The frequency of uterine leiomyomas. Am J Clin Pathol. 1990;94(4):435-8. doi: 10.1093/ajcp/94.4.435
2. Sefah N, Ndebele S, Prince L, Korasare E, Agbleke M, Nkansah A et al. Uterine fibroids - Causes, impact, treatment, and lens to the African perspective. Front Pharmacol. 2023;13:1045783. doi: 10.3389/fphar.2022.1045783
3. Wang HM, Tian YC, Xue ZF, Zhang Y, Dai YM. Associations between uterine fibroids and obstetric outcomes in twin pregnancies. Int J Gynaecol Obstet. 2016;135(1):22-7. doi: 10.1016/j.ijgo.2016.04.013
4. Kuznetsova MV, Tonoyan NM, Trubnikova EV, Zelensky DV, Svirepova KA, Adamyan LV et al. Novel Approaches to Possible Targeted Therapies and Prophylaxis of Uterine Fibroids. Diseases. 2023;11(4):156. doi: 10.3390/diseases11040156
5. Navarro A, Bariani MV, Yang Q, Al-Hendy A. Understanding the Impact of Uterine Fibroids on Human Endometrium Function. Front Cell Dev Biol. 2021;9:633180. doi: 10.3389/fcell.2021.633180
6. Zemni I, Aloui M, Saadallah F, Mansouri H, Chargui R, Ben Dhiab T. A huge prolapsed cervical leiomyoma: A case report. Int J Surg Case Rep. 2023;106:108139. doi: 10.1016/j.ijscr.2023.108139
7. Choudhary A, Inamdar SA, Sharma U. Pregnancy With Uterine Fibroids: Obstetric Outcome at a Tertiary Care Hospital of Central India. Cureus. 2023;15(2):e35513. doi: 10.7759/cureus.35513
8. Lee HJ, Norwitz ER, Shaw J. Contemporary management of fibroids in pregnancy. Rev Obstet Gynecol. 2010 Winter;3(1):20-7
9. Saleh HS, Mowafy HE, Hameid AAAE, Sherif HE, Mahfouz EM. Does Uterine Fibroid Adversely Affect Obstetric Outcome of Pregnancy? Biomed Res Int. 2018;2018:8367068. doi: 10.1155/2018/8367068
10. Eze CU, Odumeru EA, Ochie K, Nwadike UI, Agwuna KK. Sonographic assessment of pregnancy co-existing with uterine leiomyoma in Owerri, Nigeria. Afr Health Sci. 2013;13(2):453-60. doi: 10.4314/ahs.v13i2.36
11. Sankaran SM, Pillai JS. Fetomaternal outcome in fibroid complicating pregnancy: a retrospective study. Int J Reprod Contracept Obstet Gynecol. 2021;10(7):1-7. doi: 10.18203/2320-1770.ijrcog20212330
12. Handa N, Anjali. Feto maternal outcomes of fibroid in pregnancy: a retrospective observational study. Int J Reprod Contracept Obstet Gynecol. 2023;12(10):3080-5. doi: 10.18203/2320-1770.ijrcog20232951
13. Posh S, Rafiq S, Nisa Quraishi AU, Wani S. Obstetric outcome in pregnancies complicated with fibroids: A prospective observational study. Matrix Sci Med 2021;5(1):12-6. doi: 10.4103/MTSM.MTSM_39_20
14. Shaima, Jan HT, Aslam L, Ali F, Gul M, Ali MH. Impact of uterine fibroids on pregnancy outcomes: analysis from a tertiary care hospital. J Populat Therapeut Clin Pharmacol. 2024;31(6):777-783. doi: 10.53555/jptcp.v31i6.6569
15. Pandit U, Singh M, Ranjan R. Assessment of Maternal and Fetal Outcomes in Pregnancy Complicated by Fibroid Uterus. Cureus. 2022;14(2):e22052. doi: 10.7759/cureus.22052
16. Bhat P, Patel A, Pukale RS. Maternal and fetal outcomes in pregnancy complicated by fibroid uterus. India J Obstet Gynecol Res. 2019;6(4):435-439. doi: 10.18231/j.ijogr.2019.095
17. Zhao SK, Wu P, Jones SH, Torstenson ES, Hartmann KE, Velez Edwards DR. Association of uterine fibroids with birthweight and gestational age. Ann Epidemiol. 2020;50:35-40.e2. doi: 10.1016/j.annepidem.2020.06.012
18. Don EE, Mijatovic V, Huirne JAF. Infertility in patients with uterine fibroids: a debate about the hypothetical mechanisms. Hum Reprod. 2023;38(11):2045-2054. doi: 10.1093/humrep/dead194
19. Sundermann AC, Aldridge TD, Hartmann KE, Jones SH, Torstenson ES, Edwards DRV. Uterine fibroids and risk of preterm birth by clinical subtypes: a prospective cohort study. BMC Pregnancy Childbirth. 2021;21(1):560. doi: 10.1186/s12884-021-03968-2
20. Landman AJEMC, Don EE, Vissers G, Ket HCJ, Oudijk MA, de Groot CJM et al. The risk of preterm birth in women with uterine fibroids: A systematic review and meta-analysis. PLoS One. 2022;17(6):e0269478. doi: 10.1371/journal.pone.0269478
21. Al Sulaimani R, Machado L, Al Salmi M. Do Large Uterine Fibroids Impact Pregnancy Outcomes? Oman Med J. 2021;36(4):e292. doi: 10.5001/omj.2021.93.
Downloads
Published
How to Cite
Issue
Section
License
Copyright (c) 2025 Journal of Liaquat University of Medical & Health Sciences
This work is licensed under a Creative Commons Attribution-NonCommercial-ShareAlike 4.0 International License.
Submission of a manuscript to the journal implies that all authors have read and agreed to the content of the undertaking form or the Terms and Conditions.
When an article is accepted for publication, the author(s) retain the copyright and are required to grant the publisher the right of first publication and other non-exclusive publishing rights to JLUMHS.
Articles published in the Journal of Liaquat University of Medical & health sciences are open access articles under a Creative Commons Attribution-Noncommercial - Share Alike 4.0 License. This license permits use, distribution and reproduction in any medium; provided the original work is properly cited and initial publication in this journal. This is in accordance with the BOAI definition of open access. In addition to that users are allowed to remix, tweak and build upon the work non-commercially as long as appropriate credit is given and the new creations are licensed under the identical terms. Or, in certain cases it can be stated that all articles and content there in are published under creative commons license unless stated otherwise.
